Leadership Overview
OrthoPediatrics has 4 executives leading key functions including strategy, trauma reconstruction, trauma and deformity, and scoliosis.
Driven by innovation, OrthoPediatrics is dedicated to designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions, impacting pediatric care globally.
Driven by innovation, OrthoPediatrics is dedicated to designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions, impacting pediatric care globally.
Leadership Roles at OrthoPediatrics
David Bailey - President & Chief Executive Officer
David Bailey, the President & Chief Executive Officer at OrthoPediatrics, directs the overarching strategy and execution of the company's mission. Bailey oversees the design, development, and marketing of specialized orthopedic implants, instruments, and braces tailored for pediatric patients. This leadership role ensures the company's continued focus on anatomically appropriate solutions for children facing orthopedic conditions across the United States and international markets. Bailey's strategic vision guides the expansion of product lines, including pediatric trauma and deformity correction, scoliosis procedures, and sports medicine offerings. The Chief Executive Officer drives operational efficiency and fosters innovation within the organization, ensuring OrthoPediatrics maintains its position as a leader in pediatric orthopedics. By championing advancements in medical device technology, David Bailey directly supports improved patient outcomes and addresses critical unmet needs in the pediatric healthcare sector.

Timothy Hinspeter - President, Trauma Recon Corporate (An Orthopediatrics Distributor)
Timothy Hinspeter, the President, Trauma Recon Corporate (An Orthopediatrics Distributor) at OrthoPediatrics, spearheads the distribution and strategic growth of trauma reconstruction products. Hinspeter manages relationships with key distribution partners, ensuring seamless access to OrthoPediatrics' specialized implants and instruments for pediatric trauma cases. This executive focuses on expanding market penetration for trauma and deformity correction solutions within the United States and internationally. The President, Trauma Recon Corporate (An Orthopediatrics Distributor) drives sales initiatives and supports the commercialization efforts for these critical pediatric orthopedic devices. Hinspeter's leadership ensures that healthcare providers have the necessary tools to address complex pediatric orthopedic injuries effectively. By optimizing the supply chain and distribution network, Timothy Hinspeter directly contributes to the company's ability to serve young patients requiring advanced trauma care.
Joseph Hauser - President, Trauma & Deformity Business
Joseph Hauser, the President, Trauma & Deformity Business at OrthoPediatrics, directs the strategic development and commercialization of products for pediatric trauma and deformity correction. Hauser oversees the entire lifecycle of these specialized orthopedic solutions, from initial design concepts to market launch and ongoing support. This leadership position involves close collaboration with engineering and clinical teams to ensure the anatomical appropriateness and efficacy of implants and instruments. The President, Trauma & Deformity Business drives market share growth by identifying new opportunities and strengthening relationships with orthopedic surgeons specializing in pediatric care. Hauser's focus ensures that OrthoPediatrics continues to innovate in addressing complex bone fractures and congenital deformities in children. By championing advanced surgical techniques and device technologies, Joseph Hauser significantly impacts the treatment of pediatric orthopedic conditions.

Gregory Odle - President - Scoliosis
Gregory Odle, the President - Scoliosis at OrthoPediatrics, leads the strategic direction and business operations for the company's scoliosis product portfolio. Odle oversees the development, marketing, and sales of specialized implants and instruments designed for pediatric spinal deformity correction procedures. This executive role ensures OrthoPediatrics remains at the forefront of innovation in treating adolescent idiopathic scoliosis and other spinal conditions affecting children. The President - Scoliosis drives market expansion and fosters strong relationships with spine surgeons and healthcare institutions globally. Odle's leadership focuses on enhancing the efficacy and accessibility of surgical treatments for pediatric spinal deformities. By advancing the technology and clinical application of scoliosis correction systems, Gregory Odle directly contributes to improving the quality of life for young patients with spinal conditions.

Explore Leadership Teams in Manufacturing
Founded in 1966, Medline Industries is a national manufacturer and distributor of health care supplies and services. Medline provides products and services to the entire continuum of care, including hospitals, extended care facilities, surgery centers, commercial laundries, home care dealers, home care agencies, physician offices. Medline is located in Northfield, Illinois.
Company Leadership

EH
Miracle-Ear, a division of Amplifon Group, has been a trusted resource in hearing solutions for over 70 years. Based in Minneapolis, MN, Miracle-Ear specializes in customizable hearing solutions that feature discreet, comfortable products designed to meet each individual's hearing loss needs.
Company Leadership AS
PK
BR
MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The companys proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications; OrthoFlo, an amniotic fluid-derived allograft for homologous applications; Physio, a bone grafting material comprising 100% bone tissue with no added carrier; and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. The company also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue; AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process; and AmnioFill, a cellular tissue matrix allograft that enhances healing. Its products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. The company sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group, Inc. is headquartered in Marietta,...
Company Leadership
DM
WH
DR
Founded in 2000 and headquartered in Port Washington, New York, Drive DeVilbiss Healthcare is a company that manufactures a line of durable medical equipment including mobility products, beds, bariatric products, wheelchairs, and more.
Company Leadership DL
EM

RA